Pharmacokinetics and bioavailability of oxytetracycline in gilthead sea bream (Sparus aurata) after a single dose

被引:60
作者
Rigos, G [1 ]
Nengas, I
Tyrpenou, AE
Alexis, M
Troisi, GA
机构
[1] Natl Ctr Marine Res, Lab Fish Nutr & Pathol, GR-16604 Ellinikon, Attiki, Greece
[2] Kingston Univ, Sch Life Sci, Kingston upon Thames KT1 2EE, Surrey, England
[3] Inst Vet Res Athens, Dept Residue Res, HPLC Lab, Natl Agr Res Fdn, Athens 15310, Greece
[4] Brunel Univ, Environm Monitoring Unit, Dept Mech Engn, Uxbridge UB8 3PH, Middx, England
关键词
oxytetracyline; gilthead sea bream (Sparus aurata); pharmacokinetics; bioavailability;
D O I
10.1016/S0044-8486(03)00071-1
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
This is the first study to investigate the pharmacokinetic parameters of oxytetracycline (OTC) in gilthead sea bream (Sparus aurata). Following a single intravascular injection of OTC (40 mg/kg) in 100 g fish kept at 20 degreesC, the distribution half-life (t(1/2alpha)) and the elimination half-life (t(1/2beta)) of OTC were found to be long (2 and 53 h, respectively). The drug was well distributed throughout the internal body compartments since the apparent volume of distribution of the drug at steady-state (V-d(ss)) and the apparent volume of distribution by the area method (V-d(area)) were found to be high (2.9 and 3.8 l/kg, respectively). OTC had a long mean residence time (MRT) (56 h) but a short total clearance (CLT) (0.05 l/kg h). The slow elimination of the drug suggests a need for long withdrawal periods prior to use of dosed fish for human consumption. Although the bioavailability (F%) of OTC following oral administration in aqueous suspension (75 mg/kg) was calculated to be low (9%), maximum OTC plasma concentration was relatively high (2.5 mug/ml), indicating that current therapeutic regimens applied to gilthead sea bream might be effective against bacterial pathogens. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 23 条
[1]   Comparative pharmacokinetics and bioavailability of oxytetracycline in rainbow trout and chinook salmon [J].
Abedini, S ;
Namdari, R ;
Law, FCP .
AQUACULTURE, 1998, 162 (1-2) :23-32
[2]  
Baggot J. D., 1977, PRINCIPLES DRUG DISP
[3]   TEMPERATURE-RELATED ABSORPTION AND EXCRETION OF OXYTETRACYCLINE IN RAINBOW-TROUT (SALMO-GAIRDNERI R) [J].
BJORKLUND, H ;
BYLUND, G .
AQUACULTURE, 1990, 84 (3-4) :363-372
[4]  
BJORKLUND HV, 1991, XENOBIOTICA, V21, P1511
[5]   PHARMACOKINETIC AND TISSUE DISTRIBUTION STUDY OF OXYTETRACYCLINE IN RAINBOW-TROUT FOLLOWING BOLUS INTRAVENOUS ADMINISTRATION [J].
BLACK, WD ;
FERGUSON, HW ;
BYRNE, P ;
CLAXTON, MJ .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1991, 14 (04) :351-358
[6]   DIGESTIBILITY OF CHLORAMPHENICOL, OXOLINIC ACID AND OXYTETRACYCLINE IN RAINBOW-TROUT AND INFLUENCE OF THESE ANTIBIOTICS ON LIPID DIGESTIBILITY [J].
CRAVEDI, JP ;
CHOUBERT, G ;
DELOUS, G .
AQUACULTURE, 1987, 60 (02) :133-141
[7]   BILIARY-EXCRETION OF [C-14] TAUROCHOLATE BY RAINBOW-TROUT (SALMO-GAIRDNERI) IS STIMULATED AT WARMER ACCLIMATION TEMPERATURE [J].
CURTIS, LR ;
KEMP, CJ ;
SVEC, AV .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1986, 84 (01) :87-90
[8]   Bioavailability of oxytetracycline from medicated feed administered to Atlantic salmon (Salmo salar L) in seawater [J].
Elema, MO ;
Hoff, KA ;
Kristensen, HG .
AQUACULTURE, 1996, 143 (01) :7-14
[9]  
Ellis A.E., 1978, P13
[10]   COMPARATIVE PHARMACOKINETICS OF OXYTETRACYCLINE IN RAINBOW-TROUT (SALMO-GAIRDNERI) AND AFRICAN CATFISH (CLARIAS-GARIEPINUS) [J].
GRONDEL, JL ;
NOUWS, JFM ;
SCHUTTE, AR ;
DRIESSENS, F .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1989, 12 (02) :157-162